Sumitomo Dainippon, Takeda to terminate joint development deal of Latuda
Latuda is an atypical antipsychotic developed by Sumitomo, while it is characterized by a chemical structure and an affinity for dopamine D2, serotonin 5-HT2A and serotonin 5-HT7 receptors
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.